Common Contracts
2 similar Standstill Agreement contracts by Vertex Pharmaceuticals Inc / Ma
ContractStandstill Agreement • May 5th, 2020
EX-99.1 2 ex4.htm EXHIBIT 4 - STANDSTILL AGREEMENT Exhibit 4 Execution Version STANDSTILL AGREEMENT THIS STANDSTILL AGREEMENT (this “Agreement”) is made and entered into as of June 6, 2019 (the “Effective Date”), by and between CRISPR Therapeutics AG, a stock corporation (Aktiengesellschaft) organized under the laws of Switzerland (the “Company”), and Vertex Pharmaceuticals Incorporated (“Vertex Parent”) and Vertex Pharmaceuticals (Europe) Limited (“Vertex UK” and, together with Vertex Parent, “Vertex”). The Company, Vertex Parent and Vertex UK each may be referred to herein individually as a “Party” or collectively as the “Parties”. WHEREAS, the Parties and certain of their Affiliates (as defined below) have entered into that certain (i) Strategic Collaboration, Option and License Agreement dated as of October 26, 2015 (such agreement, as originally executed and as the same has been or may be amended, restated, modified or supplemented in accordance with its terms, is referred to as t
STANDSTILL AGREEMENTStandstill Agreement • June 7th, 2019 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations
THIS STANDSTILL AGREEMENT (this “Agreement”) is made and entered into as of June 6, 2019 (the “Effective Date”), by and between CRISPR Therapeutics AG, a stock corporation (Aktiengesellschaft) organized under the laws of Switzerland (the “Company”), and Vertex Pharmaceuticals Incorporated (“Vertex Parent”) and Vertex Pharmaceuticals (Europe) Limited (“Vertex UK” and, together with Vertex Parent, “Vertex”). The Company, Vertex Parent and Vertex UK each may be referred to herein individually as a “Party” or collectively as the “Parties”.
